U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Estimated coverage to address financial barriers to HIV preexposure prophylaxis among persons with indications for its use, United States, 2015

Supporting Files
File Language:
English


Details

  • Alternative Title:
    J Acquir Immune Defic Syndr
  • Personal Author:
  • Description:
    Background

    An estimated 1.2 million American adults engage in sexual and drug use behaviors that place them at significant risk of acquiring HIV infection. Engagement in health care for the provision of daily oral antiretroviral medication as preexposure prophylaxis (PrEP), when clinically indicated, could substantially reduce the number of new HIV infections in these persons. However, resources to cover the financial cost of PrEP care is an anticipated barrier for many of the populations with high numbers of new HIV infections.

    Methods

    Using nationally representative data, we estimated the current national met and unmet need for financial assistance with covering the cost of PrEP medication, clinical visits, and laboratory costs among adults with indications for its use, overall and by transmission risk population.

    Results

    This study found that, of the 1.2 million adults estimated to have indications for PrEP use, <1% (∼7,300) are in need of financial assistance for both PrEP medication and clinical care, at an estimated annual cost of $89 million. An additional 7% (∼86,300) are in need of financial assistance only for PrEP clinical care at an estimated annual cost of $119 million.

    Conclusion

    This information on PrEP care costs, insurance coverage, and unmet financial need among persons in key HIV transmission risk subpopulations can inform policy makers at all levels as they consider how to address remaining financial barriers to the use of PrEP and accommodate any changes in eligibility for various insurance and financial assistance programs that may occur in coming years.

  • Subjects:
  • Keywords:
  • Source:
    J Acquir Immune Defic Syndr. 76(5):465-472
  • Pubmed ID:
    28834798
  • Pubmed Central ID:
    PMC5821499
  • Document Type:
  • Funding:
  • Volume:
    76
  • Issue:
    5
  • Collection(s):
  • Main Document Checksum:
    urn:sha256:d05e0b6f8e9fe492d1fdd84ae1bce292553d56e71d19693bb5964a68bac9192d
  • Download URL:
  • File Type:
    Filetype[PDF - 409.89 KB ]
File Language:
English
ON THIS PAGE

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.